Matches in SemOpenAlex for { <https://semopenalex.org/work/W1569171808> ?p ?o ?g. }
Showing items 1 to 80 of
80
with 100 items per page.
- W1569171808 endingPage "13" @default.
- W1569171808 startingPage "1" @default.
- W1569171808 abstract "Objective. To evaluate the efficacy and safety of Xuezhikang capsule treating type 2 diabetes with hyperlipidemia. Methods. We searched six databases to identify relevant studies published before January 2015. Two review authors independently extracted data and assessed the Cochrane risk of bias tool. We resolved disagreements with this assessment through discussion and a decision was achieved by consensus. Results. We included 21 studies (1548 participants). Treatment courses were at least 8 weeks. Overall, the risk of bias of included trials was unclear. Among them, 16 studies could conduct meta-analysis. The result showed that compared with routine group (5 studies), Xuezhikang group had more effect on decreasing TC, TG, LDL-C, and rising HDL-C. However, compared with statins group (11 studies), Xuezhikang group has less effect on decreasing TC, TG, and rising HDL-C. Meanwhile, two groups had no statistical differences of LDL-C level. Conclusion. Xuezhikang capsule may be effective for treating type 2 diabetes with hyperlipemia. Our findings should be considered cautiously due to unclear risk of bias of the included studies and low methodological quality. Therefore, more strictly designed large-scale randomized clinical trials are needed to evaluate the efficacy of Xuezhikang capsule in type 2 diabetes with hyperlipemia." @default.
- W1569171808 created "2016-06-24" @default.
- W1569171808 creator A5025384599 @default.
- W1569171808 creator A5034995105 @default.
- W1569171808 creator A5036134333 @default.
- W1569171808 creator A5049140425 @default.
- W1569171808 creator A5050344464 @default.
- W1569171808 creator A5070020550 @default.
- W1569171808 creator A5074227380 @default.
- W1569171808 date "2015-01-01" @default.
- W1569171808 modified "2023-10-15" @default.
- W1569171808 title "Xuezhikang Capsule for Type 2 Diabetes with Hyperlipemia: A Systematic Review and Meta-Analysis of Randomized Clinical Trails" @default.
- W1569171808 cites W1969894862 @default.
- W1569171808 doi "https://doi.org/10.1155/2015/468520" @default.
- W1569171808 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4515518" @default.
- W1569171808 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26246836" @default.
- W1569171808 hasPublicationYear "2015" @default.
- W1569171808 type Work @default.
- W1569171808 sameAs 1569171808 @default.
- W1569171808 citedByCount "3" @default.
- W1569171808 countsByYear W15691718082020 @default.
- W1569171808 countsByYear W15691718082022 @default.
- W1569171808 countsByYear W15691718082023 @default.
- W1569171808 crossrefType "journal-article" @default.
- W1569171808 hasAuthorship W1569171808A5025384599 @default.
- W1569171808 hasAuthorship W1569171808A5034995105 @default.
- W1569171808 hasAuthorship W1569171808A5036134333 @default.
- W1569171808 hasAuthorship W1569171808A5049140425 @default.
- W1569171808 hasAuthorship W1569171808A5050344464 @default.
- W1569171808 hasAuthorship W1569171808A5070020550 @default.
- W1569171808 hasAuthorship W1569171808A5074227380 @default.
- W1569171808 hasBestOaLocation W15691718081 @default.
- W1569171808 hasConcept C126322002 @default.
- W1569171808 hasConcept C134018914 @default.
- W1569171808 hasConcept C168563851 @default.
- W1569171808 hasConcept C2777180221 @default.
- W1569171808 hasConcept C2778778583 @default.
- W1569171808 hasConcept C2779091943 @default.
- W1569171808 hasConcept C535046627 @default.
- W1569171808 hasConcept C555293320 @default.
- W1569171808 hasConcept C59822182 @default.
- W1569171808 hasConcept C71924100 @default.
- W1569171808 hasConcept C86803240 @default.
- W1569171808 hasConcept C95190672 @default.
- W1569171808 hasConceptScore W1569171808C126322002 @default.
- W1569171808 hasConceptScore W1569171808C134018914 @default.
- W1569171808 hasConceptScore W1569171808C168563851 @default.
- W1569171808 hasConceptScore W1569171808C2777180221 @default.
- W1569171808 hasConceptScore W1569171808C2778778583 @default.
- W1569171808 hasConceptScore W1569171808C2779091943 @default.
- W1569171808 hasConceptScore W1569171808C535046627 @default.
- W1569171808 hasConceptScore W1569171808C555293320 @default.
- W1569171808 hasConceptScore W1569171808C59822182 @default.
- W1569171808 hasConceptScore W1569171808C71924100 @default.
- W1569171808 hasConceptScore W1569171808C86803240 @default.
- W1569171808 hasConceptScore W1569171808C95190672 @default.
- W1569171808 hasFunder F4320321001 @default.
- W1569171808 hasLocation W15691718081 @default.
- W1569171808 hasLocation W15691718082 @default.
- W1569171808 hasLocation W15691718083 @default.
- W1569171808 hasLocation W15691718084 @default.
- W1569171808 hasOpenAccess W1569171808 @default.
- W1569171808 hasPrimaryLocation W15691718081 @default.
- W1569171808 hasRelatedWork W1563850031 @default.
- W1569171808 hasRelatedWork W2348039225 @default.
- W1569171808 hasRelatedWork W2358144348 @default.
- W1569171808 hasRelatedWork W2363293830 @default.
- W1569171808 hasRelatedWork W2370296599 @default.
- W1569171808 hasRelatedWork W2380612784 @default.
- W1569171808 hasRelatedWork W2383009242 @default.
- W1569171808 hasRelatedWork W2386338263 @default.
- W1569171808 hasRelatedWork W2440409259 @default.
- W1569171808 hasRelatedWork W2903040050 @default.
- W1569171808 hasVolume "2015" @default.
- W1569171808 isParatext "false" @default.
- W1569171808 isRetracted "false" @default.
- W1569171808 magId "1569171808" @default.
- W1569171808 workType "article" @default.